Taisha HALTED and reOPEN -25%
Update Neurogene:
Neurogene Announces First Patient Dosed in High-Dose Cohort of NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
High-dose NGN-401 has been well-tolerated, and low-dose NGN-401 continues to show a favorable safety profile
Interim safety data presented at the International Rett Syndrome Foundation (IRSF) ASCEND Summit
https://ir.neurogene.com/news-relea...-first-patient-dosed-high-dose-cohort-ngn-401
- Forums
- ASX - By Stock
- Competitors to Daybue
Taisha HALTED and reOPEN -25% Update Neurogene: Neurogene...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.65 |
Change
-0.330(1.65%) |
Mkt cap ! $2.548B |
Open | High | Low | Value | Volume |
$19.92 | $20.04 | $19.61 | $1.256M | 63.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 44 | $19.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.65 | 350 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 30 | 19.630 |
3 | 223 | 19.620 |
4 | 389 | 19.610 |
5 | 393 | 19.600 |
3 | 726 | 19.590 |
Price($) | Vol. | No. |
---|---|---|
19.650 | 145 | 9 |
19.660 | 395 | 7 |
19.670 | 467 | 6 |
19.680 | 686 | 8 |
19.690 | 579 | 5 |
Last trade - 13.12pm 19/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online